H. K. Lv

Xiaomi LLM-Core Team, Zihao Yue, Zhenru Lin et al. · pku

We open-source MiMo-VL-7B-SFT and MiMo-VL-7B-RL, two powerful vision-language models delivering state-of-the-art performance in both general visual understanding and multimodal reasoning. MiMo-VL-7B-RL outperforms Qwen2.5-VL-7B on 35 out of 40 evaluated tasks, and scores 59.4 on OlympiadBench, surpassing models with up to 78B parameters. For GUI grounding applications, it sets a new standard with 56.1 on OSWorld-G, even outperforming specialized models such as UI-TARS. Our training combines four-stage pre-training (2.4 trillion tokens) with Mixed On-policy Reinforcement Learning (MORL) integrating diverse reward signals. We identify the importance of incorporating high-quality reasoning data with long Chain-of-Thought into pre-training stages, and the benefits of mixed RL despite challenges in simultaneous multi-domain optimization. We also contribute a comprehensive evaluation suite covering 50+ tasks to promote reproducibility and advance the field. The model checkpoints and full evaluation suite are available at https://github.com/XiaomiMiMo/MiMo-VL.

Juntao Li, Haobin Yuan, Ling Luo et al.

Intelligent drug recommendation based on Electronic Health Records (EHRs) is critical for improving for improving the quality and efficiency of clinical decision-making. By leveraging large-scale patient data, drug recommendation systems can assist physicians in selecting the most appropriate medications according to a patient's medical history, diagnoses, laboratory results, and comorbidities. However, the advancement of such systems is significantly hampered by the scarcity of publicly available, real-world EHR datasets, particularly in languages other than English. In this work, we present CDrugRed, a first publicly available Chinese drug recommendation dataset focused on discharge medications for metabolic diseases. The dataset includes 5,894 de-identified records from 3,190 patients, containing comprehensive information such as patient demographics, medical history, clinical course, and discharge diagnoses. We assess the utility of CDrugRed by benchmarking several state-of-the-art large language models (LLMs) on the discharge medication recommendation task. Experimental results show that while supervised fine-tuning improves model performance, there remains substantial room for improvement, with the best model achieving the F1 score of 0.5648 and Jaccard score of 0.4477. This result highlights the complexity of the clinical drug recommendation task and establishes CDrugRed as a challenging and valuable resource for developing more robust and accurate drug recommendation systems. The dataset is publicly available to the research community under the data usage agreements at https://github.com/DUTIR-BioNLP/CDrugRed.

Tengxiao Lv, Ling Luo, Juntao Li et al.

Accurate recognition of biomedical named entities is critical for medical information extraction and knowledge discovery. However, existing methods often struggle with nested entities, entity boundary ambiguity, and cross-lingual generalization. In this paper, we propose a unified Biomedical Named Entity Recognition (BioNER) framework based on Large Language Models (LLMs). We first reformulate BioNER as a text generation task and design a symbolic tagging strategy to jointly handle both flat and nested entities with explicit boundary annotation. To enhance multilingual and multi-task generalization, we perform bilingual joint fine-tuning across multiple Chinese and English datasets. Additionally, we introduce a contrastive learning-based entity selector that filters incorrect or spurious predictions by leveraging boundary-sensitive positive and negative samples. Experimental results on four benchmark datasets and two unseen corpora show that our method achieves state-of-the-art performance and robust zero-shot generalization across languages. The source codes are freely available at https://github.com/dreamer-tx/LLMNER.